Business France is excited to offer you the opportunity to listen to an interesting case study while enjoying breakfast on Thursday June 6th at 9:15am at the French Pavilion (Booth #2109).
Entering the most prominent market for the life sciences industry is not only challenging, but it also requires time, adaptability, robust science and strong notoriety.
We will discuss the story of Nanobiotix, a French biotech that entered the U.S. market through Massachusetts and thereby very successfully developed its footprint and business in the United States. Why did Nanobiotix choose Massachusetts? In what ways did Nanobiotix contribute to, and benefit from, the local ecosystem? How did Nanobiotix overcome the various challenges that most foreign companies are faced with when seeking collaborations with local actors?
Supported by the international law firm of McDermott Will & Emery, this discussion will include a Q&A session to allow you to ask specific questions to the panelists and learn from both their experience and their expertise.
Success Story: How a French Biotech Company Leveraged Massachusetts to Enter the U.S. Market?
• Patrick Tricoli – CEO of Nanobiotix Corp.
• Travis McCready – President & CEO of the Massachusetts Life Sciences Center
Moderated by Jennifer Bock – Attorney of McDermott Will & Emery LLP
Regitration : https://www.eventbrite.com/e/success-story-how-a-french-biotech-company-leveraged-massachusetts-to-enter-the-us-market-tickets-61511019114
Session ID: 565839